Financials
Financial year 2025
PHARMAROCK INTERNATIONAL from Destelbergen, company number BE0458842068, closed financial year 2025 with a result of € 77,208 after tax. For that financial year PHARMAROCK INTERNATIONAL recorded a gross margin of € 123,751 and equity of € 495,863. Compared with financial year 2024, the result moved from € 84,017 to € 77,208. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 27, 2026.
€ 495,863
▲ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 77,208
▼ 8% vs 2024
Profit after tax over the fiscal year.
€ 283,309
▲ 11% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 59,114 paid out
77 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 1,466
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,460
Supplier invoices still open on the last day of the fiscal year.
€ 7,262
▼ 30% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 133,435 | € 124,291 | € 131,519 | € 123,751 | ▼ 6% |
| Profit after taxes | € 81,631 | € 78,223 | € 84,017 | € 77,208 | ▼ 8% |
| Equity | € 383,168 | € 427,076 | € 477,769 | € 495,863 | ▲ 4% |
| Total debts | € 50,323 | € 8,699 | € 11,842 | € 8,755 | ▼ 26% |
| Cash | € 172,089 | € 190,155 | € 254,966 | € 283,309 | ▲ 11% |
| Land & buildings | € 241,872 | € 227,257 | € 214,094 | € 199,291 | ▼ 7% |
| Retained profit | € 364,568 | € 408,476 | € 459,169 | € 477,263 | ▲ 4% |
| Dividend | € 34,379 | € 34,314 | € 33,324 | € 59,114 | ▲ 77% |
| Balance sheet total | € 433,491 | € 435,775 | € 489,612 | € 504,618 | ▲ 3% |
Key figures of PHARMAROCK INTERNATIONAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMAROCK INTERNATIONAL?
What happened at PHARMAROCK INTERNATIONAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 77,208 (▼ 8% vs 2024). Source: NBB ↗
- Sabine De Rocker became a director. NBB
- New establishment in Destelbergen. KBO
- Start of the company according to the CBE. KBO
In short
From € 81,631 profit in 2022 to € 77,208 profit in 2025.
Paid € 123,205 in corporate taxes since 2022.
Best year ever: 2024, with € 84,017 profit.
Paid out € 161,132 in dividends to the owners in total.
Management
Behind PHARMAROCK INTERNATIONAL is Sabine De Rocker.
Directors
According to the 2025 annual accounts
Sabine De Rocker
Director
since 2020
Establishments
Establishment units
Physical locations of this company
Steilvoordehof(HEU) 6A
9070 Destelbergen
Steilvoordehof(HEU) 6 box A
9070 Destelbergen
Active since 18 October 1996
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0458.842.068
- VAT number
- BE 0458.842.068
- Registered office
- Steilvoordehof(HEU) 6A, 9070 Destelbergen
- Names & denominations
- PHARMAROCK INTERNATIONAL
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 20 September 1996
- Peppol
- Active · Active since 13 Nov 2025
- Activities · NACE
Handelsbemiddeling in de groothandel in andere specifieke goederen
Handelsbemiddeling gespecialiseerd in overige goederen, n.e.g.
Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen